AI Article Synopsis

  • Liver cirrhosis is a major health issue globally, causing around 2 million deaths annually, with various causes including viral infections, toxins, autoimmune diseases, and metabolic disorders.
  • Common symptoms of cirrhosis include jaundice, nausea, vomiting, and abnormal liver enzymes, with imaging often showing liver fibrosis.
  • A case study is presented of a 38-year-old woman with cirrhosis characterized by a mass compressing the inferior vena cava, which is an unusual manifestation compared to typical fibrotic changes.

Article Abstract

Liver cirrhosis is a significant global health burden, accounting for approximately 2 million deaths per year worldwide. The underlying etiologies of cirrhosis include viral hepatitis (hepatitis B, C, and D), toxins (such as alcohol and drugs), autoimmune diseases, cholestatic conditions (including primary biliary cholangitis and primary sclerosing cholangitis), vascular disorders (such as Budd-Chiari syndrome, sinusoidal obstruction syndrome, and cardiac cirrhosis), and metabolic disorders (including hemochromatosis, nonalcoholic steatohepatitis, and alpha-1 antitrypsin deficiency). Patients with liver cirrhosis typically present with symptoms such as jaundice, scleral icterus, nausea, and vomiting, accompanied by abnormal liver enzyme levels. Other defining features include spider angiomas, caput medusa, and esophageal and/or rectal varices. Abdominal imaging often reveals fibrotic changes within the liver. In this article, we present a case of a 38-year-old female presenting with signs and symptoms of cirrhosis, with subsequent imaging revealing a Porta hepatis mass compressing the inferior vena cava (IVC). The patient underwent a biopsy consistent with liver cirrhosis. This case is unique in the presentation of her liver cirrhosis as a compressive mass rather than the usual fibrotic changes within the liver parenchyma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11424902PMC
http://dx.doi.org/10.1016/j.radcr.2024.08.074DOI Listing

Publication Analysis

Top Keywords

liver cirrhosis
20
liver
8
cirrhosis
8
mass compressing
8
compressing inferior
8
inferior vena
8
vena cava
8
fibrotic changes
8
changes liver
8
unusual case
4

Similar Publications

Coagulopathy in acute liver failure.

Best Pract Res Clin Gastroenterol

December 2024

Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address:

Acute liver failure (ALF) is a rare but rapidly progressing syndrome, marked by severe liver dysfunction and altered mental status. While definitions of ALF vary across different guidelines, with timelines ranging from 4 to 26 weeks between jaundice onset and encephalopathy, the key defining features remain encephalopathy and coagulopathy. Elevated coagulation markers, particularly prothrombin time and international normalized ratio, have traditionally been associated with bleeding risks.

View Article and Find Full Text PDF

Bone quality analysis of the mandible in alcoholic liver cirrhosis: Anatomical, microstructural, and microhardness evaluation.

Bone

December 2024

Center of Bone Biology, Institute for Anatomy, Faculty of Medicine, University of Belgrade, Serbia; Dr Subotica starijeg 4, 11000 Belgrade, Serbia. Electronic address:

Objectives: Alcoholic bone disease has been recognized in contemporary literature as a systemic effect of chronic ethanol consumption. However, evidence about the specific influence of alcoholic liver cirrhosis (ALC) on mandible bone quality is scarce. The aim of this study was to explore microstructural, compositional, cellular, and mechanical properties of the mandible in ALC individuals compared with a healthy control group.

View Article and Find Full Text PDF

Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study.

Clin Nutr

December 2024

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States of America; Department of Medicine, Boston VA Healthcare System, Boston, MA 02130, United States of America.

Background & Aims: Renin-independent aldosteronism (RIA) refers to a spectrum of autonomous aldosterone hypersecretion. We aimed to explore the genetical relationship between RIA and metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis.

Methods: We included 125357 participants from the cohort of United Kingdom Biobank.

View Article and Find Full Text PDF

Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.

Liver Int

January 2025

Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Background And Aims: In response to direct-acting antivirals (DAAs) therapy, patients who experience a decrease in hepatic venous pressure gradient (HVPG) considerably reduce liver complications and have increased survival. This study aimed to assess the metabolomic changes associated with the changes in HVPG from the start of DAA therapy until 48 weeks after effective DAA therapy in patients with advanced HCV-related cirrhosis.

Methods: We carried out a multicenter longitudinal study in 31 patients with advanced hepatitis C virus (HCV)-related cirrhosis.

View Article and Find Full Text PDF

Objective: To develop and compare machine learning models based on CT morphology features, serum biomarkers, and basic physical conditions to predict esophageal variceal bleeding.

Materials And Methods: Two hundred twenty-four cirrhotic patients with esophageal variceal bleeding and non-bleeding were included in the retrospective study. Clinical and serum biomarkers were used in our study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!